SeaStar Medical Holding Co. (NASDAQ:ICU) Short Interest Update

SeaStar Medical Holding Co. (NASDAQ:ICU) saw a significant growth in short interest in December. As of December 15th, there was short interest totalling 518,200 shares, a growth of 53.3% from the November 30th total of 338,100 shares. Based on an average trading volume of 203,700 shares, the short-interest ratio is presently 2.5 days. Approximately 12.1% of the shares of the stock are short sold.

SeaStar Medical Stock Performance

ICU traded down $0.05 during trading on Friday, reaching $2.04. The stock had a trading volume of 129,912 shares, compared to its average volume of 215,122. The business has a 50-day moving average of $2.52 and a 200-day moving average of $4.88. SeaStar Medical has a one year low of $1.69 and a one year high of $42.92. The stock has a market cap of $9.10 million, a PE ratio of -0.18 and a beta of -1.13.

SeaStar Medical Company Profile

SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome.